111 related articles for article (PubMed ID: 16277027)
41. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
42. Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene.
Ferguson PJ; Brisson AR; Koropatnick J; Vincent MD
Cancer Lett; 2009 Feb; 274(2):279-89. PubMed ID: 18986763
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
Wesolowska O; Molnár J; Motohashi N; Michalak K
Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
[TBL] [Abstract][Full Text] [Related]
44. Synthesis of curcumin mimics with multidrug resistance reversal activities.
Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
[TBL] [Abstract][Full Text] [Related]
45. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
[TBL] [Abstract][Full Text] [Related]
46. 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.
Shah A; Naliapara Y; Sureja D; Motohashi N; Kawase M; Miskolci C; Szabo D; Molnár J
Anticancer Res; 1998; 18(4C):3001-4. PubMed ID: 9713499
[TBL] [Abstract][Full Text] [Related]
47. Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.
Wesolowska O; Wisniewski J; Bielawska-Pohl A; Paprocka M; Duarte N; Ferreira MJ; Dus D; Michalak K
Anticancer Res; 2010 Nov; 30(11):4587-93. PubMed ID: 21115910
[TBL] [Abstract][Full Text] [Related]
48. JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells.
Chaoui D; Faussat AM; Majdak P; Tang R; Perrot JY; Pasco S; Klein C; Marie JP; Legrand O
Cytometry B Clin Cytom; 2006 May; 70(3):189-96. PubMed ID: 16568474
[TBL] [Abstract][Full Text] [Related]
49. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
[TBL] [Abstract][Full Text] [Related]
50. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
51. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
52. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract][Full Text] [Related]
53. Benzo[b]-1,8-naphthyridine derivatives: synthesis and reversal activity on multidrug resistance.
Misbahi H; Brouant P; Hevér A; Molnár AM; Wolfard K; Spengler G; Mefetah H; Molnár J; Barbe J
Anticancer Res; 2002; 22(4):2097-101. PubMed ID: 12174889
[TBL] [Abstract][Full Text] [Related]
54. [Effect of neferine on adriamycin-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance].
Ai XH; Tang XQ; Liu YP; Liu HQ; Dong L
Ai Zheng; 2007 Apr; 26(4):357-60. PubMed ID: 17430651
[TBL] [Abstract][Full Text] [Related]
55. 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.
Das U; Kawase M; Sakagami H; Ideo A; Shimada J; Molnár J; Baráth Z; Bata Z; Dimmock JR
Bioorg Med Chem; 2007 May; 15(10):3373-80. PubMed ID: 17383883
[TBL] [Abstract][Full Text] [Related]
56. Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.
Spengler G; Kincses A; Rácz B; Varga B; Watanabe G; Saijo R; Sekiya H; Tamai E; Maki J; Molnár J; Kawase M
Anticancer Res; 2018 Nov; 38(11):6181-6187. PubMed ID: 30396935
[TBL] [Abstract][Full Text] [Related]
57. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.
Fong WF; Wang C; Zhu GY; Leung CH; Yang MS; Cheung HY
Phytomedicine; 2007 Feb; 14(2-3):160-5. PubMed ID: 16713217
[TBL] [Abstract][Full Text] [Related]
58. Induction of apoptosis in K562/ADM cells by gamma-linolenic acid involves lipid peroxidation and activation of caspase-3.
Kong X; Ge H; Hou L; Shi L; Liu Z
Chem Biol Interact; 2006 Aug; 162(2):140-8. PubMed ID: 16857180
[TBL] [Abstract][Full Text] [Related]
59. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
60. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Ganta S; Amiji M
Mol Pharm; 2009; 6(3):928-39. PubMed ID: 19278222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]